OTC · CIK 0001042418
INTI Inhibitor Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Apr 10, 2025.
Inhibitor Therapeutics, Inc. (INTI) has 5 SEC Form 4 filings on file from 5 insiders, the latest filed on Apr 10, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Inhibitor Therapeutics, Inc., scored.
Transactions
Every row filed, 5 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Niraj Vasisht director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | - | Apr 10, 2025 |
| Apr 1, 2025 | Michael Allen Jerman director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 80,411 | Apr 7, 2025 |
| Apr 1, 2025 | Ronald E Osman director, owner | AGrant or award Common Stockindirect: See Footnotes | +50,000 | $0.00 | $0 | 23,554,985 | Apr 7, 2025 |
| Apr 1, 2025 | Samuel P Sears Jr director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 1,279,543 | Apr 7, 2025 |
| Apr 1, 2025 | Michelle Yanez director | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 896,271 | Apr 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Michael Allen Jermandirector
- Ronald E Osmandirector, owner
- Samuel P Sears Jrdirector
- Niraj Vasishtdirector
- Michelle Yanezcfo, officer, director
Questions about INTI
Answered from the filings on this page, as of the latest one.
Are insiders buying INTI?
No. In the last 90 days no insider at Inhibitor Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade INTI on the open market?
No open-market trade has been scored at Inhibitor Therapeutics, Inc.. The latest Form 4 on file was filed on Apr 10, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Inhibitor Therapeutics, Inc.?
5 people have filed a Form 4 at Inhibitor Therapeutics, Inc., among them Michael Allen Jerman (director), Ronald E Osman (director and 10% owner), Samuel P Sears Jr (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.